This review examines recent research into modalities for improving access to sterile syringes for injection drug users (IDUs) as a means to reduce human immunodeficiency virus (HIV) transmission. English language studies with empirical data were collected through Uncover reports and MedLine searches from 1998 to 2000. Although syringeexchange programs are the most established and well-evaluated means of improving access to sterile syringes, research on alternative modalities--such as pharmacy sale, injectorspecific packs, mass distribution, and vending machines--and on coverage of special populations suggests the need to pursue multiple avenues of increasing syringe availability simultaneously and, in particular, to explore modalities other than syringe-exchange programs when HIV incidence is under control. The impacts on H1V transmission of cocaine injection and sex with IDUs need to be explored further. Finally, any evidence of declining hepatitis C incidence among young IDUs might serve as a surrogate for a sharp drop in injection-related HIV risk behaviors in that population.
INTRODUCTION
Efforts to increase the availability of sterile syringes (or needles and syringes) have should "use a new, sterile syringe to prepare and inject drugs" and should practice safe injection techniques. 2 While in the US and several other countries, political controversy often limits discussion about improving syringe availability to whether it should or should not be done, researchers have worked with the premise that improved availability of syringes aids in HIV prevention. In recent years, researchers' questions have centered on "How should we?" and "How can we achieve adequate coverage?" Syringe exchange has been the dominant modality for increasing the availability of sterile syringes in most countries. However, other modalities, or a variation on the basic syringe-exchange program (SEP) model, may be more politically feasible or, in some circumstances, more cost-effective H1V prevention. Adaptations on certain modalities may also serve special populations better, such as youth, female sex workers, prisoners, and populations in countries with emerging epidemics, and may be appropriate to respond to changes in a locality's HIV transmission rates. (This review does not address in detail issues such as syringe disposal, impact of SEPs on drug use or drug treatment, etc., because these issues do not pertain directly to reducing injection-related HIV risk behaviors; nonetheless, there are extensive data elsewhere on those subjects.)
METHODS
Survey and analysis of research on the role of syringe availability in prevention of HIV among IDUs were performed. In particular, questions about modalities for improving syringe availability and coverage of special populations were addressed. To obtain relevant research, studies were selected from periodic reviews of monthly Uncover search results in 1998 and 1999, searches of PubMed (MedLine) for papers published from 1989 to 2000, and a survey of postings to the nep@drcnet.org bulletin board. Search terms included "syringe availability," "syringe exchange," and "needle exchange." Papers were extracted in English and reviewed to confirm the reporting of empirical data related to the role of syringe availability in disease prevention among IDUs.
RESULTS
Multiperson use of syringes remains a major route of HW transmission in most developed and many developing countries. In the US, questions concerning syringe use were added to a drug use questionnaire administered by telephone to 17,747 subjects in 1995 and 18,269 subjects in 1996. 3 Of subjects who had ever injected drugs, 21 .9% reported that the last time they injected, someone had used the syringe before; 22.4% reported having passed a used syringe to others; close to 60% reported obtaining syringes only from unsafe sources (i.e., not a pharmacy or SEP). These figures suggest that efforts to improve syringe availability in the US have yet to affect a significant proportion of IDUs. Multiple modalities for improving syringe availability merit attention. 17.6 to -3.9, P = .004). 9 A study published in 1997 examined HIV seroprevalence (through fingerprick) and injecting and sexual behaviors (through self-adminis-tered questionnaire) among all participants in 21 SEPs covering all jurisdictions in Australia over a 1-week period. 1~ Data from 1,005 complete sets revealed that HIV seroprevalence was 2.1%, and that 31% of subjects reported injecting with a previously used syringe within the past month. HIV seroprevalence was significantly higher among self-described homosexuals (22.5% vs. 0.7%, P < .001), suggesting that SEPs may not address sexual risk factors adequately. A compilation of surveys involving several thousand IDUs in five US cities showed that the average number of injections per syringe declined by at least 50% after the establishment of SEPs in the cities where such an analysis could be made (New Haven, Connecticut; Baltimore, Maryland; and Chicago), and that there were statistically significant increases in the proportion of SEP participants reporting once-only use of syringes in the cities where such an analysis could be made (San Francisco, Baltimore, and Chicago). n Limitations include the retrospective nature of the analysis (i.e., none of the studies originally were intended to address these questions). In addition, the San Francisco study was small and cross sectional, the Chicago study involved a single interview and required 3 years of recall, and the Baltimore data extend only 6 months into the establishment of the SEP. 11
A study of risk behaviors before (N = 302) and after (N = 86 initial, N = 76 follow-up) the closing of the only SEP in Windham, Connecticut, examined the proportion of syringes obtained from "safe" (i.e., pharmacies and SEPs) and "unsafe" (i.e. family/friends, diabetic non-IDU, street source) sources. Results showed (1) a drop in the safe proportion from 86% before closure, to 64% within 11 months of closure, and 3 months later to 49% and (2) a rise in the unsafe proportion from 14% before closure, to 36% within 11 months of closure, and 3 months later to 51%. Data from initial interviews before and after closure were significantly different (P < .001), ~2 but authors do not address the likelihood that self-reports were influenced by media coverage.
Several studies in 14 localities or regions have measured or estimated HIV seroincidence among SEP participants (see Table I ). ~3-32 Studies in 12 locations showed similar or lower HIV seroincidence (see top 12 sites listed in Table I) among participants compared to nonparticipants, although several relied on mathematical modeling 16~8 or small sample sizes. ]4'1s Three studies in New Haven, Connecticut, tagged syringes distributed through SEPs and based conclusions on mathematical modeling and needle distribution rates, client visit dates, needle circulation times, and the fraction of returned needles that were HIV positive33; significant declines in the proportion of returned syringes that tested positive for HIV were observed. 22' 23 A meta-analysis of three studies in New York City Persistent sharers were more likely to pass used syringes to others (P < .001) and to inject cocaine on a daily basis (P < .001). SEPs generally have limited hours and, although low threshold, involve a commitment from drug users that may require significantly more effort from them, which may be more difficult to elicit from those who inject cocaine. This issue is addressed tangentially in numerous studies, but the role of cocaine in syringe use practices requires additional study.
Since 1991, eight US government-sponsored reports have reviewed SEPs, concluding that they are effective HW prevention tools (see Table II Those who trade sex and inject drugs are at particularly high risk of HIV. A comparison of female sex workers and non-sex workers at five SEPs in five US cities found that sex workers were significantly more likely to engage in a variety of HIV risk behaviors, including injecting more frequently (P < .0005), injecting daily (P < .005), injecting cocaine (P < .005), injecting speedball (P < .005), smoking crack cocaine (P < .005), reusing syringes more than twice (P < .005), backloading syringes (P < .005), attending shooting galleries (P < .005), trading used works (P < .005), obtaining syringes from non-SEP sources (P < .05), and injecting without an alcohol wipe (P < .005). 46 Based on these and other data showing, for example, that female sex workers were more likely than other female SEP participants to be under severe emotional distress (P < .0005) and to have been homeless within the past 6 months (P < .005), the authors concluded that SEPs should offer more referrals and on-site services, engage in syringe exchange in areas where sex workers stroll, encourage alternate routes of administration (sniffing, smoking), and involve sex workers in program design and implementation. These data suggest that sex workers may engage in more injection-related HIV risk behaviors that remain unaddressed by SEPs. Data from developing states support SEP-style interventions (see Table   III ). 62-~' 66-72 In the hills of Thailand, multiperson use of syringes was common prior to the introduction of SEPs. 62 Behavior change was well documented from 1993 to 1994, and HIV prevalence remained stable at 33% during that period.
The greatest difficulty was encountered in political and community agencies. 62
Interviewing 47 current and former IDUs, researchers in Manlpur, India, found No formal study has evaluated the modality of "mass distribution'--in which syringes are distributed widely through drug user networks to saturate the market--although Moving Equipment, an underground SEP in New York City, has developed a rationale and protocol. 123 The number of syringes distributed to a client is based on answers to a series of questions, including "How many works do you need today? .... How many times a day do you inject?" and "When do you plan to get more works?" In response to the concern that IDUs might take extra syringes and sell them, the distribution modality encourages secondary distribution, aiming to minimize the black market profit in syringes through market saturation. If saturation is considered an effective means of preventing HIV among IDUs, changes in the price of syringes purchased on the street may be a good measure of the success of a localized distribution intervention.
Difficult-to-reuse (DTR) syringes (e.g., those in which the needle retracts or the barrel locks after use) have been targeted at prevention programs based on the commonsense notion that, if a syringe cannot easily be reused, the risk of that syringe transmitting HW is lowered) 24 Assuming that IDUs will utilize DTR syringes (several models obstruct traditional injection techniques12S'126), it is questionable whether HIV prevention efforts would be served by their development. Probability modeling has been used to demonstrate that, if DTR syringes are introduced to IDUs and lead to a 0.7 proportional decline in the availability of regular syringes, HIV transmission rates are likely to rise (i.e., HIV risk reduction always increases by the addition of a regular syringe rather than a DTR syringe). 124 This analysis presumes that traditional syringes still will be available, and that programs function on limited resources.
A survey of 593 IDUs in seven US cities described the primary barriers to once-only use of syringes as restrictions on the availability of syringes and beliefs and practices of IDUs) 27 Distribution of DTR syringes may help modify the practices of IDUs, as was the case with SEPs, but is less likely to affect the primary concern of legal restrictions on syringe availability. Should a pilot of DTR syringes be launched, it would be prudent to select a locality with few restrictions on syringe access (i.e., exemptions from paraphernalia laws, no prescription requirement, ready access to SEPs).
Finally, an economic analysis of the costs of five different means of increasing syringe availability estimated the cost of providing a portion of the total syringes needed to ensure a new syringe for each injection in the US) 2s While an analysis of New York City, San Francisco, and Dayton, Ohio, determined that there would be a cost savings to increasing syringe availability through any modality in all three cities, the authors determined that SEPs were the most expensive means of increasing syringe availability and pharmacy sale the least expensive (see Table IV ). The most intriguing element was the estimated incidence rate and the analysis suggests that improving pharmacy access to syringes should be a top priority. This conclusion is tempered by concerns about the impact of cocaine injection and sexual risk behaviors, as well as by striking rates of injection-related HIV incidence among young IDUs. A strategy involving multiple, simultaneous modalities is ideal.
